CURRENT
ISSUE
1714

About 2.5 million persons in the US had hepatitis C between 2017 and 2020.1 Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) on management of hepatitis C virus (HCV) infection were updated in 2023.2

GENOTYPE PREVALENCE — About 70-75% of HCV infections in the US are caused by HCV genotype 1 (~50% are caused by genotype 1a), and about 20-25% are caused by genotype 2 or 3. HCV genotype 3 is associated with faster disease progression and increased rates of...  Continue reading

Coming Soon
Xanomeline/Trospium (Cobenfy) for Schizophrenia
Guselkumab (Tremfya) for Ulcerative Colitis
Lebrikizumab (Ebglyss) for Atopic Dermatitis
Drugs for Asthma